Abstract
Background
Infection with Plasmodium vivax, a common human parasite, is occasionally recognized to cause severe organ dysfunction similar to P. falciparum infection. Acute kidney injury (AKI) in malaria is attributed to acute tubular necrosis; thrombotic microangiopathy is not described.
Methods
This observational study includes patients referred to a tertiary care center in North India during June to September 2011 with severe AKI, anemia, and thrombocytopenia following vivax malaria. Renal biopsies were processed by light, immunofluorescence, and electron microscopy.
Results
Nine patients (including 5 children) had persistent AKI with thrombocytopenia and variable anemia following the diagnosis of malaria. Based on peripheral smear, eight patients were diagnosed with vivax malaria and had received antimalarial therapy prior to referral; a laboratory diagnosis of P. vivax infection was made for one patient at this center. Renal histology in all cases showed features of thrombotic microangiopathy, including fibrin thrombi, subendothelial widening, and mesangiolysis, along with variable tubulointerstitial nephritis and acute tubular or cortical necrosis. Ultrastructural examination confirmed endothelial injury and subendothelial widening. All patients required hemodialysis, and six were dialysis dependent at four weeks. Delayed presentation to the hospital (P = 0.019), hemolysis on peripheral smear (P = 0.083), and prolonged oligoanuria (P = 0.036) were associated with dialysis dependence.
Conclusion
The association of anemia, thrombocytopenia, and renal histological evidence of thrombotic microangiopathy with vivax malaria is novel, and suggests the presence of severe endothelial injury. Further studies are necessary to confirm the association and examine the factors associated with its occurrence.
Similar content being viewed by others
References
Cibulskis RE, Aregawi M, Williams R, Otten M, Dye C. Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods. PLoS Med. 2011;8:e1001142.
World Health Organization. Guidelines for the treatment of malaria. Geneva: WHO. http://www.who.int/mediacentre/news/releases/2010/malaria_20100308/en/index.html. Accessed 1 Feb 2012.
Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A. Plasmodium vivax malaria. Emerg Infect Dis. 2005;11:132–4.
Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in Northwestern India. Am J Trop Med Hyg. 2009;80:194–8.
Weber MW, Boeker K, Horstmann RD, Ehrich JH. Renal failure is a common complication in non-immune Europeans with Plasmodium falciparum malaria. Trop Med Parasitol. 1991;42:115–8.
Barsoum RS. Malaria acute renal failure. J Am Soc Nephrol. 2000;11:2147–54.
Saharan S, Kohli U, Lodha R, Sharma A, Bagga A. Thrombotic microangiopathy associated with Plasmodium vivax malaria. Pediatr Nephrol. 2009;24:623–4.
Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, et al. HPA Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines. J Infect. 2007;54:111–21.
Dragon-Durey MA, Sethi SK, Bagga A, Blanc C, Blouin J, Ranchin B, et al. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol. 2010;21:2180–7.
Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, et al. European Paediatric Research Group for HUS. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006;70:423–31.
Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Cabassi A, et al. Thrombotic-thrombocytopenic purpura following malaria prophylaxis with mefloquine. J Antimicrob Chemother. 2006;57:160–1.
Naqvi R, Ahmad E, Akhtar F, Naqvi A, Rizvi A. Outcome in severe acute renal failure associated with malaria. Nephrol Dial Transpl. 2003;18:1820–3.
Kanodia KV, Shah PR, Vanikar AV, Kasat P, Gumber M, Trivedi HL. Malaria induced acute renal failure: a single center experience. Saudi J Kidney Dis Transpl. 2010;21:1088–91.
Kaur D, Wasir V, Gulati S, Bagga A. Unusual presentation of Plasmodium vivax malaria with severe thrombocytopenia and acute renal failure. J Trop Pediatr. 2007;53:210–2.
Sharma J, Bharadawa K, Shah K, Dave S. Plasmodium vivax malaria presenting as hemolytic-uremic syndrome. Indian Pediatr. 1993;30:369–71.
Kute VB, Goswami JG, Vanikar AV, Shah PR, Gumber MR, Patel HV, et al. Unusual presentation of Plasmodium vivax: a neglected human malaria parasite. Parasitol Res. 2011;. doi:10.1007/s00436-011-2776-7.
Kute VB, Shah PR, Munjappa BC, Gumber MR, Patel HV, Jain SH, et al. Outcome and prognostic factors of malaria-associated acute kidney injury requiring hemodialysis: a single center experience. Indian J Nephrol. 2012;22:33–8.
Ehrich JHH, Eke FU. Malaria-induced renal damage: facts and myths. Pediatr Nephrol. 2007;22:626–37.
Adonis-Koffy L. May Plasmodium falciparum induce a hemolytic uremic syndrome? Arch Pediatr. 2004;11:55–6.
Rui-Mei L, Kara AU, Sinniah R. Dysregulation of cytokine expression in tubulointerstitial nephritis associated with murine malaria. Kidney Int. 1998;53:845–52.
Prakash J, Gupta A, Kumar O, Rout SB, Malhotra V, Srivastava PK. Acute renal failure in falciparum malaria—increasing prevalence in some areas of India—a need for awareness. Nephrol Dial Transpl. 1996;11:2414–6.
Kim H, Higgins S, Liles WC, Kain KC. Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics. Curr Opin Hematol. 2011;18:177–85.
Carvalho BO, Lopes SCP, Nogueira PA, Orlandi PP, Bargieri DY, Blanco YC, et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis. 2010;202:638–47.
Ohnishi K. Serum levels of thrombomodulin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in the acute phase of Plasmodium vivax malaria. Am J Trop Med Hyg. 1999;60:248–50.
de Mast Q, Groot E, Asih PB, Syafruddin D, Oosting M, Sebastian S. al. ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria. Am J Trop Med Hyg. 2009;80:492–8.
Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis. 2009;22:430–5.
Acknowledgments
The renal histology slides were also reviewed by Sanjeev Sethi, M.D., Ph.D., Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sinha, A., Singh, G., Bhat, A.S. et al. Thrombotic microangiopathy and acute kidney injury following vivax malaria. Clin Exp Nephrol 17, 66–72 (2013). https://doi.org/10.1007/s10157-012-0656-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-012-0656-9